MARIA WILLIAMS: Open Payments
NPI 1427508522 · MORGAN CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,153 in 56 payments from 23 companies in 2025. Trend: 2023 $650 · 2024 $560 · 2025 $1,153
Food & beverage: $1,153
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $213 |
| Novo Nordisk Inc | 4 | $157 |
| Lilly USA, LLC | 4 | $78 |
| Xeris Pharmaceuticals, Inc. | 3 | $68 |
| Janssen Biotech, Inc. | 3 | $66 |
| Ascendis Pharma Endocrinology Inc | 3 | $64 |
| TOLMAR, INC. | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Tandem Diabetes Care, Inc. | 2 | $46 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
Products named: Ozempic, SYNTHROID, RINVOQ, GVOKE HYPOPEN, TREMFYA, Yorvipath, JATENZO, MOUNJARO.
Industry payments across LA — which companies pay providers there.
